Ligand · XT5
XT5 · 5-[(4-cyclopropyl-1,2,3-triazol-1-yl)methyl]-2-(2-methylphenoxy)phenol
XT5, 5-[(4-cyclopropyl-1,2,3-triazol-1-yl)methyl]-2-(2-methylphenoxy)phenol (C19 H19 N3 O2, 321.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the…
- Component
- XT5
- Formula
- C19 H19 N3 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
XT5 in 2 structures; the first of them:
- 5UGS · Crystal structure of M. tuberculosis InhA inhibited by PT501 · XT5 A302 · binds GLY96, PHE97, MET98, MET103, PHE149, MET155, PRO156, ALA157 and 11 more
- 5UGS · Crystal structure of M. tuberculosis inha inhibited by PT501 · XT5 A302 · binds GLY96, PHE97, MET98, MET103, PHE149, MET155, PRO156, ALA157 and 7 more
Residues it binds most
MET 12, ALA 13, PHE 12, LEU 14, PRO 12, GLY 12, ILE 12, TYR 12, LYS 11, GLN 10 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.